Trial intelligence / Profile preview

Lumigan 0.01% vs Travatan Z vs Xalatan in Glaucoma or Ocular Hypertension

NCT01253902Phase 4Completed

Sponsor
Allergan
Start
Dec 2010
Primary completion
Oct 2011
Countries
2
01

Overview

A Phase 4 trial of bimatoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Allergan. Started Dec 2010; status: completed.

02

Drugs

bimatoprost
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on NCT01253902.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01253902.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call